Forecasts data is unavailable for this security.
Consensus recommendation
- 16-Nov-23
- 15-Aug-24
- 19-Sep-24
- 17-Oct-24
- 07-Nov-24
Select bar for recommendation details.
Recommendations | 07-Nov-24 | |
---|---|---|
Buy | 2 | |
Outperform | 1 | |
Hold | 3 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in CNY
The 6 analysts offering 12 month price targets for Everest Medicines Ltd have a median target of 25.77, with a high estimate of 43.68 and a low estimate of 24.33. The median estimate represents a -28.92% decrease from the last price of 36.25.
High | 20.5% | 43.68 |
Med | -28.9% | 25.77 |
Low | -32.9% | 24.33 |
Earnings history & estimates in CNY
Average growth rate | -1,261.83% |
More ▼
Revenue history & estimates in CNY
Average growth rate | +12,236.67% |
More ▼